Coated or Chewable Aspirin and a Hybrid Strategy to Mitigate Adverse Effects of Air Pollution in Stable Atherosclerotic Disease

NCT06541691 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

3000

Enrollment

OTHER

Sponsor class

Conditions

Atherosclerotic Cardiovascular Disease
Coronary Artery Disease
Ischemic Heart Disease
Ischemic Stroke
Peripheral Arterial Disease
Carotid Artery Stenosis
Carotid Atherosclerosis

Interventions

DRUG: Enteric-coated aspirin
DRUG: Plain aspirin
OTHER: Hybrid strategy

Sponsor

Rajaie Cardiovascular Medical and Research Center

Collaborators

[object Object]